NDC product
Stona
NDC 49873-301 · Sato Pharmaceutical Co., Ltd.
Key facts
| Product NDC | 49873-301 |
|---|---|
| Proprietary name | Stona |
| Nonproprietary name | dextromethorphan hydrobromide |
| Substances | DEXTROMETHORPHAN HYDROBROMIDE |
| Dosage form | LOZENGE |
| Route | ORAL |
| Labeler | Sato Pharmaceutical Co., Ltd. |
| Product type | HUMAN OTC DRUG |
| Marketing category | OTC MONOGRAPH DRUG |
| Application number | M012 |
| Pharmacologic classes | Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA] |
| Marketing start | Nov 19, 1995 |
| Listing certified through | Dec 31, 2026 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: